Published in J Med Virol on November 01, 1993
Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Bull World Health Organ (1997) 2.33
Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of "carrier' and "non-carrier' cattle. Epidemiol Infect (1996) 0.90
Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies. Clin Diagn Lab Immunol (2005) 0.85
Evaluation of commercial rubella immunoglobulin G avidity assays. J Clin Microbiol (2006) 0.84
Evaluation of rubella virus immunoglobulin G (IgG) and IgM assays with the new Vidia instrument. J Clin Microbiol (2008) 0.82
Immunoglobulin G avidity in the serodiagnosis of congenital rubella syndrome. Eur J Clin Microbiol Infect Dis (1997) 0.82
Identification of Serologic Markers for School-Aged Children With Congenital Rubella Syndrome. J Infect Dis (2014) 0.77
Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet (1982) 4.56
Serum IgM and IgG responses in postnatally acquired rubella. Lancet (1969) 4.16
Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories. J Hyg (Lond) (1980) 4.13
A serological method for demonstrating recent infection by rubella virus. Br Med J (1967) 4.07
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet (1995) 3.93
IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent technique. J Hyg (Lond) (1972) 3.47
Effect of selective vaccination on rubella susceptibility and infection in pregnancy. Br Med J (Clin Res Ed) (1985) 2.48
Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48
Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol (1987) 2.42
Serological assessment of rubella during pregnancy. Br Med J (1970) 2.37
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med (2001) 2.33
The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev (1994) 2.32
The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect (2000) 2.25
Rapid diagnosis of respiratory syncytial virus infection in children by the immunofluorescent technique. J Clin Pathol (1971) 2.20
Outcome of asymptomatic infection with rubella virus during pregnancy. J Hyg (Lond) (1981) 2.15
A rationalised virological electron microscope specimen testing policy. PHLS North West Viral Gastroenteritis and Electron Microscopy Subcommittee. J Clin Pathol (1999) 2.09
Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet (1985) 2.08
Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis (1983) 2.07
New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines. HIV Med (2008) 1.99
Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health (1989) 1.92
Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin Exp Immunol (1996) 1.90
Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect (1995) 1.89
Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis (2005) 1.87
Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet (1981) 1.86
Specific immunoglobulins in infants with the congenital rubella syndrome. J Hyg (Lond) (1976) 1.83
Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM. Lancet (1975) 1.78
Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma. Lancet (1972) 1.73
A comparison of three tests for rubella antibody screening. J Clin Pathol (1979) 1.71
The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J (1995) 1.67
Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) (1982) 1.66
Prevalence of antibodies to Norwalk virus in England: detection by enzyme-linked immunosorbent assay using baculovirus-expressed Norwalk virus capsid antigen. J Clin Microbiol (1993) 1.66
Letter: Rubella-specific IgM and a new inhibitor. Br Med J (1974) 1.66
Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood (1998) 1.65
Rubella immunity by four different techniques: results of challenge studies. J Med Virol (1980) 1.58
Comparison of immunofluorescence and radioimmunoassay for detecting IgM antibody in infants with the congenital rubella syndrome. J Hyg (Lond) (1979) 1.57
Studies on rubella virus strain variation by kinetic haemagglutination-inhibition tests. J Gen Virol (1970) 1.56
Ten years of serological surveillance in England and Wales: methods, results, implications and action. Int J Epidemiol (2000) 1.55
Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood (1999) 1.51
Human parvovirus and the fetus. Lancet (1985) 1.50
Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect (1995) 1.50
Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet (1989) 1.48
PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol (1995) 1.47
Fast and type-specific analysis of herpes simplex virus types 1 and 2 by rapid PCR and fluorescence melting-curve-analysis. Infection (2000) 1.46
Rubella-specific IgM reactivity in sera from cases of infectious mononucleosis. J Hyg (Lond) (1983) 1.45
Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol (2001) 1.44
Rash in early pregnancy. Br Med J (Clin Res Ed) (1983) 1.43
Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect (1988) 1.43
Age-specific antibody prevalence to hepatitis A in England: implications for disease control. Epidemiol Infect (1994) 1.43
Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule. Commun Dis Rep CDR Rev (1997) 1.40
bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A (1995) 1.40
Biological effects of shock waves: lung hemorrhage by shock waves in dogs--pressure dependence. Ultrasound Med Biol (1987) 1.39
Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis. Infect Immun (1997) 1.38
Cancer associated human papillomaviruses: perinatal transmission and persistence. Br J Obstet Gynaecol (1994) 1.38
Veterinary nursing examinations. Vet Rec (1994) 1.38
Rubella-specific IgM detection using Sephacryl S-300 gel filtration. J Clin Pathol (1980) 1.36
End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation (1989) 1.36
Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol (2000) 1.35
Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect (2006) 1.34
Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS (1999) 1.33
British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med (2008) 1.33
Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev (1994) 1.32
Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods (1992) 1.32
Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) (1984) 1.30
Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge. J Infect Dis (1980) 1.30
Human rotavirus serotypes. Lancet (1981) 1.29
Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (2001) 1.26
New Japanese rubella vaccine: comparative trials. Br Med J (1974) 1.26
Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect (2004) 1.26
Maternal rubella at St Thomas' Hospital in 1978 and 1986: support for augmenting the rubella vaccination programme. Lancet (1987) 1.26
Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J Clin Virol (1999) 1.26
Shock waves for gallstones: animal studies. Lancet (1983) 1.25
Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM. J Hyg (Lond) (1983) 1.25
Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine (2002) 1.24
Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis (1999) 1.23
Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology (1997) 1.22
The role of environmental contamination with small round structured viruses in a hospital outbreak investigated by reverse-transcriptase polymerase chain reaction assay. J Hosp Infect (1998) 1.22
A comparison of Rubazyme-M and MACRIA for the detection of rubella-specific IgM. J Virol Methods (1984) 1.21
Prenatal diagnosis of intrauterine rubella. Infection (1987) 1.21
Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes. Biochem Pharmacol (1987) 1.20
Specific IgG subclass antibody in rubella virus infections. Epidemiol Infect (1988) 1.20
Detection of high risk HPV and Chlamydia trachomatis in vaginal and cervical samples collected with flocked nylon and wrapped rayon dual swabs transported in dry tubes. J Virol Methods (2009) 1.18
Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees. J Infect Dis (1985) 1.18
An evaluation of nine commercial EIA kits for the detection of measles specific IgG. J Virol Methods (1997) 1.17
Immunisation of nurses with a live varicella vaccine. Lancet (1985) 1.15
Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines. J Hyg (Lond) (1978) 1.15
Specific immunoglobulin responses after varicella and herpes zoster. J Hyg (Lond) (1979) 1.15
Comparison of the performance and reproducibility of various serological methods and diagnostic kits for the detection of rubella antibodies. J Virol Methods (1985) 1.14
The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol Infect (1999) 1.14
A comparison of RK-13, vervet monkey kidney and patas monkey kidney cell cultures for the isolation of rubella virus. J Hyg (Lond) (1967) 1.14